Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/21645515.2020.1781507 http://scihub22266oqcxt.onion/10.1080/21645515.2020.1781507 32693665!7899667!32693665     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hum+Vaccin+Immunother 2021 ; 17 (2): 414-415 Nephropedia Template TP {{tp|p=32693665|t=2021. COVID-19 - Important considerations for developing and using a vaccine |pdf=|usr=}}{{32693665}} gab.com Text COVID-19 - Important considerations for developing and using a vaccine JO: Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=32693665 #FOAvip The novel coronavirus SARS-CoV-2 after emerging in China has caused a global pandemic that is risking the lives of millions. COVID-19 has spread across the world at a very rapid rate raising concerns of capacity limitations and lack of unified responses at the global level, particularly from the world's most developed countries. The spread of further infection has been curtailed by lockdown and mass social distancing that has been enforced in most parts of the world. There are no clinical data yet suggesting that any available candidate vaccine will be effective for COVID-19 which will be a critical need for eventually preventing this disease. Extensive research is underway with some success in identification of monoclonal antibodies from COVID-19 recovered patients, which may inform on vaccine development. The clinical evaluations of COVID-19 vaccines need to follow standardized protocols that are essential for safeguarding humans. In absence of a vaccine or a widely available effective therapy, quarantine and other preventive measures are essential in curtailing the risk of pandemic spread. Twit Text FOAVip COVID-19 - Important considerations for developing and using a vaccine ????Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=32693665 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32693665 #FOAvip English Wikipedia <ref>{{Cite pmid|32693665}}</ref> COVID-19 - Important considerations for developing and using a vaccine #MMPMID32693665 Rahman IU; Ali N; Ijaz F; Afzal A; Abd Allah EF Hum Vaccin Immunother 2021[Feb]; 17 (2): 414-415 PMID32693665show ga The novel coronavirus SARS-CoV-2 after emerging in China has caused a global pandemic that is risking the lives of millions. COVID-19 has spread across the world at a very rapid rate raising concerns of capacity limitations and lack of unified responses at the global level, particularly from the world's most developed countries. The spread of further infection has been curtailed by lockdown and mass social distancing that has been enforced in most parts of the world. There are no clinical data yet suggesting that any available candidate vaccine will be effective for COVID-19 which will be a critical need for eventually preventing this disease. Extensive research is underway with some success in identification of monoclonal antibodies from COVID-19 recovered patients, which may inform on vaccine development. The clinical evaluations of COVID-19 vaccines need to follow standardized protocols that are essential for safeguarding humans. In absence of a vaccine or a widely available effective therapy, quarantine and other preventive measures are essential in curtailing the risk of pandemic spread. |Antibodies, Monoclonal/administration & dosage/chemistry[MESH] |COVID-19 Vaccines/*administration & dosage/chemical synthesis[MESH] |COVID-19/epidemiology/*prevention & control[MESH] |Communicable Disease Control/*methods[MESH] |Drug Development/*methods[MESH] |Humans[MESH]COVID-19 - Important considerations for developing and using a vaccine(epmc).pdf DeepDyve Pubget Overpricing